vs

Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $83.1M, roughly 1.4× PROCEPT BioRobotics Corp). DULUTH HOLDINGS INC. runs the higher net margin — -8.8% vs -38.1%, a 29.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -9.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -31.6%).

Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DLTH vs PRCT — Head-to-Head

Bigger by revenue
DLTH
DLTH
1.4× larger
DLTH
$114.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+29.8% gap
PRCT
20.2%
-9.6%
DLTH
Higher net margin
DLTH
DLTH
29.3% more per $
DLTH
-8.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-31.6%
DLTH

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
DLTH
DLTH
PRCT
PRCT
Revenue
$114.9M
$83.1M
Net Profit
$-10.1M
$-31.6M
Gross Margin
53.8%
64.9%
Operating Margin
-7.7%
-4.1%
Net Margin
-8.8%
-38.1%
Revenue YoY
-9.6%
20.2%
Net Profit YoY
64.6%
-27.9%
EPS (diluted)
$-0.29
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLTH
DLTH
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$114.9M
$76.4M
Q3 25
$131.7M
$83.3M
Q2 25
$102.7M
$79.2M
Q1 25
$241.3M
$69.2M
Q4 24
$127.1M
$68.2M
Q3 24
$141.6M
$58.4M
Q2 24
$116.7M
$53.4M
Net Profit
DLTH
DLTH
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-10.1M
$-29.8M
Q3 25
$1.3M
$-21.4M
Q2 25
$-15.3M
$-19.6M
Q1 25
$-5.6M
$-24.7M
Q4 24
$-28.2M
$-18.9M
Q3 24
$-2.0M
$-21.0M
Q2 24
$-7.9M
$-25.6M
Gross Margin
DLTH
DLTH
PRCT
PRCT
Q1 26
64.9%
Q4 25
53.8%
60.6%
Q3 25
54.7%
64.8%
Q2 25
52.0%
65.4%
Q1 25
44.1%
63.9%
Q4 24
52.3%
64.0%
Q3 24
52.3%
63.2%
Q2 24
52.8%
59.0%
Operating Margin
DLTH
DLTH
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-7.7%
-40.6%
Q3 25
1.8%
-27.8%
Q2 25
-12.0%
-28.0%
Q1 25
-1.8%
-39.7%
Q4 24
-17.4%
-28.9%
Q3 24
-1.1%
-38.4%
Q2 24
-7.7%
-50.3%
Net Margin
DLTH
DLTH
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-8.8%
-39.1%
Q3 25
1.0%
-25.7%
Q2 25
-14.9%
-24.7%
Q1 25
-2.3%
-35.8%
Q4 24
-22.2%
-27.6%
Q3 24
-1.4%
-35.9%
Q2 24
-6.7%
-48.0%
EPS (diluted)
DLTH
DLTH
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.29
$-0.54
Q3 25
$0.04
$-0.38
Q2 25
$-0.45
$-0.35
Q1 25
$-0.17
$-0.45
Q4 24
$-0.84
$-0.34
Q3 24
$-0.06
$-0.40
Q2 24
$-0.24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLTH
DLTH
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$8.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$160.6M
$347.7M
Total Assets
$468.0M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLTH
DLTH
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$8.2M
$286.5M
Q3 25
$5.7M
$294.3M
Q2 25
$8.6M
$302.7M
Q1 25
$3.3M
$316.2M
Q4 24
$9.3M
$333.7M
Q3 24
$9.8M
$196.8M
Q2 24
$6.8M
$214.1M
Total Debt
DLTH
DLTH
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
DLTH
DLTH
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$160.6M
$365.9M
Q3 25
$170.0M
$380.3M
Q2 25
$167.9M
$385.8M
Q1 25
$182.7M
$389.2M
Q4 24
$188.1M
$402.2M
Q3 24
$215.7M
$241.2M
Q2 24
$218.4M
$251.8M
Total Assets
DLTH
DLTH
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$468.0M
$508.1M
Q3 25
$433.8M
$511.5M
Q2 25
$463.7M
$513.1M
Q1 25
$452.4M
$519.4M
Q4 24
$533.1M
$534.0M
Q3 24
$488.6M
$374.1M
Q2 24
$471.4M
$374.4M
Debt / Equity
DLTH
DLTH
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLTH
DLTH
PRCT
PRCT
Operating Cash FlowLast quarter
$-6.7M
Free Cash FlowOCF − Capex
$-8.9M
FCF MarginFCF / Revenue
-7.8%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLTH
DLTH
PRCT
PRCT
Q1 26
Q4 25
$-6.7M
$-10.3M
Q3 25
$32.0M
$-6.6M
Q2 25
$-56.5M
$-15.0M
Q1 25
$41.2M
$-17.0M
Q4 24
$-41.1M
$-32.4M
Q3 24
$16.6M
$-18.8M
Q2 24
$-33.7M
$-15.7M
Free Cash Flow
DLTH
DLTH
PRCT
PRCT
Q1 26
Q4 25
$-8.9M
$-12.2M
Q3 25
$29.8M
$-9.5M
Q2 25
$-57.8M
$-17.8M
Q1 25
$38.7M
$-18.8M
Q4 24
$-43.7M
$-33.6M
Q3 24
$15.0M
$-19.0M
Q2 24
$-35.2M
$-16.8M
FCF Margin
DLTH
DLTH
PRCT
PRCT
Q1 26
Q4 25
-7.8%
-15.9%
Q3 25
22.6%
-11.4%
Q2 25
-56.3%
-22.5%
Q1 25
16.0%
-27.2%
Q4 24
-34.4%
-49.2%
Q3 24
10.6%
-32.6%
Q2 24
-30.2%
-31.4%
Capex Intensity
DLTH
DLTH
PRCT
PRCT
Q1 26
Q4 25
2.0%
2.4%
Q3 25
1.7%
3.4%
Q2 25
1.3%
3.5%
Q1 25
1.0%
2.7%
Q4 24
2.1%
1.7%
Q3 24
1.2%
0.4%
Q2 24
1.3%
2.0%
Cash Conversion
DLTH
DLTH
PRCT
PRCT
Q1 26
Q4 25
Q3 25
25.40×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLTH
DLTH

Sales Channel Directly To Consumer$67.4M59%
Sales Channel Through Intermediary$47.4M41%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons